CEO and founder of ProofPilot, Matthew Amsden, is today’s guest interview.
Matthew talks to us about his company ProofPilot. He explains how it is making research easily available to consumer good companies that traditionally didn’t have opportunities to run these types of studies.
We then find out about the type of products that can be tested, how the research can be conducted remotely and who can participate in the studies.
We also go into discussing managing placebos, using alternatives such as case controls or wait-list controls, study reliability, avoiding conflict of interest and removing incentives bias, third party review, as well as advice on how to use clinical research in the health decision making process.
Go to the show notes for BioHackers Lab podcast episode 113 at https://www.biohackerslab.com/ep113-matthew-amsden/ for more links & highlights.